American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and …
K Cusi, S Isaacs, D Barb, R Basu, S Caprio… - Endocrine Practice, 2022 - Elsevier
Objective To provide evidence-based recommendations regarding the diagnosis and
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement
The term non-alcoholic fatty liver disease (NAFLD), and its definition, have limitations for
both adults and children. The definition is most problematic for children, for whom alcohol …
both adults and children. The definition is most problematic for children, for whom alcohol …
Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity
SE Hampl, SG Hassink, AC Skinner, SC Armstrong… - …, 2023 - publications.aap.org
You have in your hands, or at your fingertips, the first edition of the American Academy of
Pediatrics clinical practice guideline for evaluation and management of children and …
Pediatrics clinical practice guideline for evaluation and management of children and …
the epidemiologic burden of non‐alcoholic fatty liver disease across the world
L Henry, J Paik, ZM Younossi - Alimentary pharmacology & …, 2022 - Wiley Online Library
Background The prevalence of non‐alcoholic fatty liver disease (NAFLD) is increasing in
parallel with obesity and type 2 diabetes. Aim To review the global epidemiology of NAFLD …
parallel with obesity and type 2 diabetes. Aim To review the global epidemiology of NAFLD …
Past, present and future perspectives in nonalcoholic fatty liver disease
AJ Sanyal - Nature reviews Gastroenterology & hepatology, 2019 - nature.com
Nonalcoholic fatty liver disease (NAFLD) was first described as a distinct clinical entity four
decades ago. However, the condition has become the centre of attention within hepatology …
decades ago. However, the condition has become the centre of attention within hepatology …
[HTML][HTML] Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is defined as the presence of hepatic fat
accumulation after the exclusion of other causes of hepatic steatosis, including other causes …
accumulation after the exclusion of other causes of hepatic steatosis, including other causes …
Pediatric obesity—assessment, treatment, and prevention: an Endocrine Society clinical practice guideline
DM Styne, SA Arslanian, EL Connor… - The Journal of …, 2017 - academic.oup.com
Abstract Cosponsoring Associations: The European Society of Endocrinology and the
Pediatric Endocrine Society. This guideline was funded by the Endocrine Society. Objective …
Pediatric Endocrine Society. This guideline was funded by the Endocrine Society. Objective …
NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on …
Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver disease that
occurs in the setting of insulin resistance and increased adiposity. It has rapidly evolved into …
occurs in the setting of insulin resistance and increased adiposity. It has rapidly evolved into …
Non-alcoholic steatohepatitis: a review of its mechanism, models and medical treatments
C Peng, AG Stewart, OL Woodman… - Frontiers in …, 2020 - frontiersin.org
Non-alcoholic steatohepatitis (NASH) develops from non-alcoholic fatty liver disease
(NAFLD). Currently, around 25% of the population is estimated to have NAFLD, and 25% of …
(NAFLD). Currently, around 25% of the population is estimated to have NAFLD, and 25% of …
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
NA Jiao, SS Baker, A Chapa-Rodriguez, W Liu… - Gut, 2018 - gut.bmj.com
Objective Bile acids are regulators of lipid and glucose metabolism, and modulate
inflammation in the liver and other tissues. Primary bile acids such as cholic acid and …
inflammation in the liver and other tissues. Primary bile acids such as cholic acid and …